Art. -Nr.: HY-N6951

Guaiazulene

Kundenbewertung

Based on 1 Customer Validation

Guaiazulene is a bicyclic sesquiterpene. Guaiazulene exhibits various biological activities such as anti-inflammatory, antioxidant, hepatoprotective, antibacterial, and anti-tumor properties. Guaiazulene is also commonly used as a colorant in cosmetics. Guaiazulene shows in vitro cytotoxicity to rat neuronal cells and N2a neuroblastoma cells at high concentrations.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Reinheit: 99.08%
CAS. Nr.: 489-84-9
Formel: C₁₅H₁₈
Molecular Weight:198.30

Speicherung:

Pure form -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month

Guaiazulene Chemical Structure

CAS. Nr.: 489-84-9

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- In Vitro
- In Vivo
Chemical Information
Lösungsmittel & Löslichkeit
- In Vitro
- In Vivo
Reinheit & Dokumentation
Verweise
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

Alle Akt Isoform-spezifische Produkte anzeigen :

Alle mTOR Isoform-spezifische Produkte anzeigen :

Alle Caspase Isoform-spezifische Produkte anzeigen :

In Vitro

Guaiazulene (≥150 μg/mL; 24 h) can reduce the cell viability, inhibit the total antioxidant capacity, but has no obvious DNA damage in N2a and rat neurons^[1].
Guaiazulene (5-20 μM; 0-45 min) significantly inhibits lipid peroxidation in rat liver microsomes with an IC₅₀ of 9.8 μM^[2].
Guaiazulene (0-250 μM; 48 h) can inhibit the proliferation, reduce clone formation, and induce ROS accumulation and cell apoptosis of non-small cell lung cancer cell lines^[3].
Guaiazulene (0-150 μM; 24-48 h) triggers a complete autophagic flux in non-small cell lung cancer cell lines A549 and H1975 by inhibiting the Akt/mTOR signaling pathway^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[2]

Cell Line:

Primary rat neurons and N2a NB cells
Concentration:

10, 25, 50, 75, 100, 150, 200, and 400 μg/mL
Incubation Time:

24 h
Result:

Did not affect cell viability at 10, 25, 50, 75, and 100 μg/mL
Inhibited the cell viability at 150, 200, and 400 μg/mL.

Cell Viability Assay^[3]

Cell Line:

Non-small cell lung cancer cell lines
Concentration:

0, 50, 100, 150, 200, and 250 μM
Incubation Time:

48 h
Result:

Inhibited the cell growth, with IC₅₀ values of 135.0, 144.7, 148.9, 109.5, 152.8, and 207.0 μM for A549, PC9, HCC827, H1975, H1299 and 16HBE, respectively.

In Vivo

Guaiazulene (250 mg/kg; intraperitoneal injection; single dose) exerts a protective effect in a rat model of liver injury^[2].
Guaiazulene (25 mg/kg; intraperitoneal injection; 3 weeks) exhibits anti-tumor activity in a nude mouse model of A549 xenograft^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Female Fischer-344 rats (180-200 g) treated Acetaminophen (Paracetamol; HY-66005) to induc liver injury^[2]
Dosage:

250 mg/kg
Administration:

Intraperitoneal injection; single dose
Result:

Restored the paracetamol-decreased hepatic glutathione level, and normalized other parameters including hepatic weight, cytosolic protein content, glutathione transferase activity, and glutathione reductase activity, which were affected by paracetamol.
Did not cause any macroscopic toxic symptoms, and its administration alone has no effect on all tested indices.

Animal Model:

Female nude mice (BALB/c, 17-19 g) aged 5 weeks old treated A549 cells^[3]
Dosage:

25 mg/kg
Administration:

Intraperitoneal injection; 3 weeks
Result:

Caused smaller size and lighter weight of tumors.
Reduced Ki67 staining intensity, while cleaved-caspase 3 intensity was increased; LC3 staining was stronger and p-Akt levels were decreased in tumor tissues.
Caused no significant changes in mouse weight or pathologic features of major organs (heart, lung, liver, spleen, kidney)

Chemical Information

CAS. Nr. 489-84-9
Appearance Solid-Liquid Mixture
Molecular Weight 198.30
Formel C₁₅H₁₈
SMILES

CC(C1=CC2=C(C)C=CC2=C(C)C=C1)C
Structure Classification
- Terpenoids
- Sesquiterpenes
Initial Source
- Plants
- other families
- Endogenous metabolite
Versand

Room temperature in continental US; may vary elsewhere.

Speicherung

Pure form	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Lösungsmittel & Löslichkeit

In Vitro:

DMSO : 50 mg/mL (252.14 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

5.0429 mL

25.2143 mL

50.4286 mL

5 mM

1.0086 mL

5.0429 mL

10.0857 mL

10 mM

0.5043 mL

2.5214 mL

5.0429 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

Stock Solution Working Solution

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline

Solubility: ≥ 6.25 mg/mL (31.52 mM); Clear solution

This protocol yields a clear solution of ≥ 6.25 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (62.5 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)

Solubility: ≥ 6.25 mg/mL (31.52 mM); Clear solution

This protocol yields a clear solution of ≥ 6.25 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (62.5 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage Dosage
mg/kg
Animal Weight (Per Animal) Animal Weight (Per Animal)
g
Dosing Volume (Per Animal) Dosing Volume (Per Animal)
μL
Number of Animals Number of Animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

%
DMSO +

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
%
+
+
%
Tween-80 + +
%
Saline +

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Working solution concentration: 0.22 mg/mL

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (285 KB)
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Togar B, et al. Guaiazulene biochemical activity and cytotoxic and genotoxic effects on rat neuron and N2a neuroblastom cells. J Intercult Ethnopharmacol. 2015 Jan-Mar;4(1):29-33. [Content Brief]

[2]. Kourounakis AP, et al. Antioxidant activity of guaiazulene and protection against paracetamol hepatotoxicity in rats. J Pharm Pharmacol. 1997 Sep;49(9):938-42. [Content Brief]

[3]. Ye Q, et al. Guaiazulene Triggers ROS-Induced Apoptosis and Protective Autophagy in Non-small Cell Lung Cancer. Front Pharmacol. 2021 Apr 15;12:621181. [Content Brief]

[4]. Akram W, et al. Guaiazulene and related compounds: A review of current perspective on biomedical applications. Life Sci. 2023 Mar 1;316:121389. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	5.0429 mL	25.2143 mL	50.4286 mL	126.0716 mL
	5 mM	1.0086 mL	5.0429 mL	10.0857 mL	25.2143 mL
	10 mM	0.5043 mL	2.5214 mL	5.0429 mL	12.6072 mL
	15 mM	0.3362 mL	1.6810 mL	3.3619 mL	8.4048 mL
	20 mM	0.2521 mL	1.2607 mL	2.5214 mL	6.3036 mL
	25 mM	0.2017 mL	1.0086 mL	2.0171 mL	5.0429 mL
	30 mM	0.1681 mL	0.8405 mL	1.6810 mL	4.2024 mL
	40 mM	0.1261 mL	0.6304 mL	1.2607 mL	3.1518 mL
	50 mM	0.1009 mL	0.5043 mL	1.0086 mL	2.5214 mL
	60 mM	0.0840 mL	0.4202 mL	0.8405 mL	2.1012 mL
	80 mM	0.0630 mL	0.3152 mL	0.6304 mL	1.5759 mL
	100 mM	0.0504 mL	0.2521 mL	0.5043 mL	1.2607 mL

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent:

Produktname:
CAS. Nr.:
Species:
Reinheit:
Menge:

Guaiazulene

Anti-Infection Compound Library

Apoptosis Compound Library

Immunology/Inflammation Compound Library

Kinase Inhibitor Library

Metabolism/Protease Compound Library

NF-κB Signaling Compound Library

PI3K/Akt/mTOR Compound Library

Stem Cell Signaling Compound Library

Natural Product Library

FDA-Approved Drug Library

Anti-Cancer Compound Library

Autophagy Compound Library

Anti-Aging Compound Library

Drug Repurposing Compound Library

Antioxidant Compound Library

Differentiation Inducing Compound Library

Reprogramming Compound Library

Lipid Compound Library

Oxygen Sensing Compound Library

Antifungal Compound Library

Antibacterial Compound Library

Ferroptosis Compound Library

NMPA-Approved Drug Library

Terpenoids Library

Glycolysis Compound Library

Cytoskeleton Compound Library

Glutamine Metabolism Compound Library

Traditional Chinese Medicine Active Compound Library

FDA Approved & Pharmacopeial Drug Library

Anti-Breast Cancer Compound Library

Anti-Lung Cancer Compound Library

Anti-Pancreatic Cancer Compound Library

Anti-Blood Cancer Compound Library

Anti-Cancer Metabolism Compound Library

Anti-Obesity Compound Library

Angiogenesis-Related Compound Library

Glucose Metabolism Compound Library

Food-Sourced Compound Library

Anti-Liver Cancer Compound Library

Anti-Colorectal Cancer Compound Library

Anti-Cancer Natural Product Library

Anti-inflammatory Traditional Chinese Medicine Active Compound Library

Plant-Sourced Natural Product Library

FDA-Approved Anticancer Drug Library

Human Metabolite Library

Anti-Prostate Cancer Compound Library

Anti-Pulmonary Fibrosis Compound Library

Non-steroidal Anti-Inflammatory Compound Library

Cancer Stem Cells Compound Library

Pain-Related Compound Library

Off-patent Drug Library

Mitochondrial Protection Compound Library

Cell Death Library

FDA-Approved Traditional Chinese Medicine Active Compound Library

Serine/Threonine Kinase Inhibitor Library

Anti-Hematopathy Compound Library

Anti-Ovarian Cancer Compound Library

Multi-Target Compound Library

Radioprotector Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Natural Product Library Plus

Drug Repurposing Compound Library Plus

FDA-Approved Drug Library Plus

FDA-Approved Drug Library Mini

Natural Product and Natural Product-Like Compound Library

Bioactive Compound Library

Anti-Gastric Cancer Compound Library

Anti-Fibrosis Compound Library

Anti-Brain Cancer Compound Library

Miao Ethnicity Medicine Compound Library

Tibetan Medicine Compound Library

Heat-Clearing and Detoxification Traditional Chinese Medicine Compound Library

Protein Kinase Compound Library

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

Cell Proliferation Compound Library

High-Throughput Bioactive Compound Library

High-Throughput Natural Product Library

Ancient Chinese Classical Formulas Traditional Chinese Medicine Active Compound Library